Pericardial effusion

Article written and reviewed by Dr Luca Moretti

A pericardial effusion is a pathological accumulation of fluid in the space between the pericardial layers. It is an anatomic sign that may accompany inflammation, systemic disease, malignancy, hemodynamic abnormalities or traumatic injury. It may be discovered incidentally or present with dyspnea, pain and circulatory compromise. The term identifies neither the cause nor the severity and must be completed by a functional and etiologic description.

Assessment is based on four elements: size, distribution, rate of change and presence of inflammation. To these is added the priority question of the impact on filling. Echocardiographic dimensions facilitate classification and follow-up, but a large collection does not necessarily mean tamponade and a small collection may be dangerous if it developed rapidly or is confined within a pocket.

Management ranges from simple observation to urgent drainage, together with treatment of the responsible disease. An appropriate decision requires distinguishing the expected benefit of decompression from that of diagnostic sampling and avoiding automatic use of anti-inflammatory drugs when there is no evidence of pericarditis.

Anatomic definition, classification and epidemiology

The physiologic fluid, generally on the order of a few tens of milliliters, reduces friction between cardiac surfaces. Its volume depends on the balance between formation and reabsorption. A thin separation of the layers should not be interpreted outside the technical context, whereas a clearly identifiable collection is described by site and extent. Cysts, epicardial fat and pleural effusion may mimic pericardial fluid and require correct anatomic identification before a diagnosis is assigned.

The echocardiographic classification uses the echo-free space measured at end-diastole: conventionally small below 10 mm, moderate between 10 and 20 mm, and large above 20 mm. The measurement should be related to the site and compared with equivalent views over time. These ranges do not provide a reliable conversion to milliliters, especially in asymmetric or localized collections, and cannot be used as the sole indication for drainage.

The distribution may be circumferential or loculated. Adhesions after surgery, infection or previous episodes may divide the sac into compartments, while clots and fibrin alter echogenicity. A posterior collection may be underestimated from some windows; an apparently complex fluid does not by itself prove pus or blood. The description should preserve these elements because they influence both assessment of consequences and selection of the route for a possible procedure.

The duration distinguishes recent forms from chronic collections, generally defined by persistence beyond three months. The time of discovery does not necessarily coincide with onset, so classification requires previous imaging or longitudinal observation. A chronic effusion may undergo new acceleration and become urgent. Likewise, a collection detected during an acute illness may be a pre-existing finding, making it necessary to avoid causal attribution based only on temporal coincidence.

Inflammatory activity is a classification axis independent of size. Typical pain, friction rub, biomarkers and tissue imaging may indicate pericarditis; the absence of these elements points toward non-inflammatory mechanisms without excluding every important cause. A normal C-reactive protein does not automatically make an effusion benign, especially in malignancy or bleeding. This distinction mainly helps select therapies and explains why some collections do not respond to NSAIDs and colchicine.

Epidemiology varies with patient origin, access to imaging and local disease prevalence. Incidental findings in a general population differ from cases seen in oncology, nephrology or cardiac surgery centers. The burden of tuberculosis also varies markedly across geographic areas and risk groups. Therefore, there is no single etiologic distribution valid for every setting; initial probabilities must be updated through history, clinical findings and results of relevant investigations.

Etiology and mechanisms of formation

Increased permeability during inflammation promotes entry of fluid and proteins. Idiopathic pericarditis, infections and immune-mediated diseases may produce collections of variable size. High fever, immunosuppression or a subacute course changes etiologic suspicion and the need for investigation. Bacterial or tuberculous disease should not be managed as common idiopathic pericarditis solely on the basis of pain or temporary improvement with anti-inflammatory treatment.

Lymphatic obstruction and neoplastic infiltration alter reabsorption and may cause effusion even with few inflammatory signs. Lung and breast cancers and hematologic malignancies are important, but not exclusive, settings. In oncology patients, causes related to radiation therapy, drugs, infections and organ dysfunction also occur. Neoplastic pericardial disease therefore requires confirmation and characterization, because attribution to the tumor may influence staging and treatment selection.

Systemic pressure abnormalities, especially venous congestion, may impair drainage and promote collections. Heart failure, pulmonary hypertension and conditions with elevated right-sided pressure alter both fluid formation and the expression of compression. Hypoalbuminemia may contribute to exchange balance, often together with other factors. The finding should be interpreted within the overall clinical picture, avoiding consideration of every effusion as a primary pericardial disease.

Metabolic causes include advanced renal failure and hypothyroidism, with different mechanisms. In uremic patients, inflammation, volume overload and hemostatic dysfunction may coexist; inadequate dialysis is an element to verify. In hypothyroidism-related pericardial effusion, accumulation may be slow and substantial, but the endocrine diagnosis does not eliminate the need to assess filling. Correction of the cause takes time and must proceed together with treatment of any urgent complications.

Iatrogenic causes include surgery, procedures, drugs and radiation. Timing of onset may point toward bleeding, post-cardiac injury inflammation or delayed damage without separating them absolutely. Hemopericardium may arise from active injury and require control of the source; a serosanguineous collection may instead accompany several different processes. Anticoagulation and coagulopathy increase complexity but should not become a substitute explanation that prevents investigation for perforation or rupture.

Idiopathic forms are defined after an investigation proportionate to the presentation, not merely after finding normal basic tests. The extent of the work-up depends on size, symptoms, risk and course. Rare causes, such as lymphatic abnormalities with chylopericardium, require specific clues. The idiopathic category remains revisable: growth, rapid reaccumulation, fever or new systemic findings should reopen etiologic reasoning even when a previous assessment was reassuring. The appearance of extracardiac signs may also indicate a more accessible and informative site for diagnostic sampling, avoiding unnecessary pericardial sampling.

Pathophysiology and clinical manifestations

Pericardial distensibility initially allows volume to be accommodated with only a modest rise in pressure. Once this reserve is exhausted, further increases may produce rapidly progressive compression. Slow accumulation allows greater adaptation than acute accumulation. Hemodynamic significance therefore cannot be derived from presumed volume alone: the relationship between external pressure and chamber pressure matters, and is modified by volume status, ventilation, cardiac function and the presence of adhesions.

Dyspnea may progress from exertional limitation to difficulty at rest and orthopnea. Fatigue, chest heaviness and reduced independence are possible, while pleuritic pain suggests an inflammatory component without being mandatory. Large collections may produce compressive symptoms on adjacent structures, more rarely dysphagia or voice changes. These symptoms are nonspecific and must be compared with respiratory, cardiac and systemic disorders often present in the same patients.

An asymptomatic finding is common and requires risk assessment, not automatic reassurance or an inevitable procedure. A patient may unknowingly adapt activities, making progressive limitation less obvious. Functional capacity, weight, heart rate and symptoms should be compared with the previous period. True stability is demonstrated in the clinical and temporal context, whereas a single examination documents only the anatomic state at that moment.

Cardiac tamponade reduces filling and output with compensatory responses. Tachycardia, elevated venous pressure, pulsus paradoxus, hypotension and hypoperfusion may occur in different combinations. The classic triad is not sufficiently sensitive to exclude the condition when incomplete. In subacute presentations, blood pressure may remain preserved; in localized collections or when right-sided pressures are elevated, some usual signs may be absent, requiring specialist interpretation of the overall findings.

Low filling pressure may make a not very high pericardial pressure clinically significant, as in hypovolemia. Aggressive diuresis or ultrafiltration may precipitate deterioration in predisposed patients. Conversely, pulmonary hypertension may mask right-sided chamber collapse and alter the balance of drainage. These situations show why decisions should not be automated on the basis of a single sign and why hemodynamic support requires individualized caution.

Residual restriction after fluid removal may result from effusive-constrictive physiology, myocardial disease or valvular lesions. Persistently elevated venous pressure should be investigated without immediately assuming inadequate drainage. Inflammation may cause transient constriction, whereas organized fibrosis causes a more durable problem. This distinction changes subsequent treatment and helps define how much of the functional deficit is actually reversible with a pericardial intervention.

Echocardiography and hemodynamic assessment

The transthoracic examination should use multiple windows to identify fluid, measure its distribution and assess its impact. A complete description includes the site of maximum thickness, extent, any loculations, echogenic material and comparison with previous studies. Distinguishing pleural effusion and epicardial fat requires correct anatomic landmarks. The study also includes the ventricles and valves, because associated dysfunction may explain part of the symptoms and affect tolerance of accumulation.

Chamber collapse reflects external pressure exceeding intracavitary pressure during specific phases of the cardiac cycle. Right atrial inversion and right ventricular diastolic collapse support suspicion of compression, but depend on volume status and pre-existing pressures. Not every brief atrial inversion corresponds to clinical tamponade; conversely, absence of collapse does not exclude it in particular conditions. Duration and concordance with other signs increase interpretive value.

Respiratory variations in atrioventricular flows express exaggerated ventricular interdependence. During spontaneous breathing, marked changes in mitral and tricuspid flow may support the diagnosis, but rhythm, heart rate and respiratory disease influence the measurements. Mechanical ventilation changes the physiology and prevents mechanical application of thresholds used during spontaneous breathing. Acquisition conditions should be reported, especially when the result guides a procedure or is compared with a later examination.

A dilated inferior vena cava with reduced inspiratory variability suggests elevated right-sided pressures but is poorly specific. Right heart failure, ventilation and pulmonary hypertension may produce the same finding. A swinging heart within a large collection is a suggestive anatomic sign, not a direct measure of urgency. The echocardiographic conclusion should integrate these elements with chamber collapse, Doppler and the clinical picture, specifying when the examination is limited or discordant.

Postoperative collections may require transesophageal echocardiography or CT for definition. Regional atrial or ventricular compression, clots and adhesions do not necessarily follow the pattern of a free effusion. An initial negative or inconclusive study should not stop investigation when clinical suspicion remains high. In an unstable patient, pursuit of the best image occurs in parallel with preparation for intervention and involvement of the team able to treat the cause.

Invasive assessment is not necessary for most effusions but may clarify complex or discordant physiology. When performed in an appropriate context, measurement of pressures before and after drainage helps identify residual restriction. Equalization of diastolic pressures is not specific by itself. The decision to proceed should answer a concrete clinical question, whereas obvious compression with deterioration does not require preliminary diagnostic catheterization to justify decompression.

Investigation of the cause and fluid analysis

The etiologic history includes recent infections, tuberculosis exposure, malignancies, autoimmune diseases, renal function, endocrine symptoms, trauma, procedures and medications. Timing and doses of therapies may be decisive. Examination looks for systemic signs, lymph nodes, skin lesions, congestion and respiratory findings. The investigation is graded according to probability: a small stable finding without symptoms does not require the same work-up as a large febrile collection in an immunosuppressed person.

Initial tests often include complete blood count, C-reactive protein, creatinine, electrolytes and liver function, with TSH and other studies when relevant. Troponin and ECG assess possible myocardial or ischemic components. Autoantibodies and microbiology are requested according to clues, avoiding indiscriminate viral or immunologic panels. Diagnostic value depends on pretest probability; an isolated positive result without a coherent phenotype should not become the official cause of the effusion.

Chest CT may identify masses, lymphadenopathy, pulmonary abnormalities, calcifications and complex distribution. Cardiac MRI is useful for inflammation and relationships with the myocardium and constriction. PET may contribute to selected oncologic questions, but metabolic uptake does not always distinguish malignancy from inflammation. Advanced modalities should be selected for the problem to be solved, not accumulated as mandatory steps. Their utility is greatest when the result changes sampling, treatment or urgency.

Cytology is fundamental when malignancy is suspected and fluid is obtained. Adequate volume, cell block and clinical information improve interpretation; immunocytochemistry and flow cytometry may be needed according to the suspicion. Negative cytology does not exclude every infiltration. If nodules, thickening or strong persistent suspicion are present, targeted biopsy may add information, whereas a random fragment does not guarantee greater sensitivity than the fluid sample.

Microbiology is adapted to the context, including bacterial cultures and mycobacterial or fungal studies when indicated. Previous treatment may reduce yield. When tuberculosis is suspected, molecular tests, culture and fluid markers must be interpreted in relation to epidemiology and availability, without assigning absolute rule-out capability to a single result. The presence of pus or strong suspicion of infection requires timely treatment and drainage without waiting for all definitive results.

Pericardial biochemistry has specific limitations. Studies of normal fluid show that proteins and lactate dehydrogenase may overlap with ranges classified as exudate by Light's pleural criteria; automatic application may therefore be misleading. What matters is synthesis with cellularity, microbiology and cytology. Triglycerides and chylomicrons help identify chylous fluid when suspected; a milky appearance is not enough. Likewise, blood requires clinical and procedural interpretation and does not by itself identify a malignant cause.

Etiologic treatment and selection of observation

Active pericarditis associated with effusion is treated according to cause and phenotype, often with aspirin or NSAIDs and colchicine when appropriate. The target is inflammation, not the mere presence of an echo-free space. A collection without inflammatory signs has no proven systematic response to these drugs. Corticosteroids and biologic therapies should likewise be reserved for defined indications, avoiding escalation solely to obtain echocardiographic normalization in the absence of active disease.

Systemic correction may include optimization of dialysis, treatment of hypothyroidism, management of congestion or therapy for an autoimmune disease. In oncology patients, control of the tumor or modification of a responsible treatment may be decisive. Improvement in fluid may take time; waiting is acceptable only if circulation and symptoms allow it. A treatable cause does not make drainage unnecessary when compromise is present and cannot wait for the etiologic response.

Small idiopathic collections that are asymptomatic and stable may not require ongoing specific echocardiographic surveillance after adequate assessment. For moderate or large collections, new findings or undefined causes, follow-up is scheduled according to risk and course. Early on, closer reassessment may be useful to establish dynamics. Subsequent frequency should not be a rigid formula: growth, symptoms or new systemic data require a change even before the planned interval.

Large chronic collections that are idiopathic, asymptomatic or minimally symptomatic and non-inflammatory constitute a distinct group. Contemporary data and updated recommendations have reduced the indication for preventive drainage based only on size and duration. Observation may be preferable after adequate investigation, in the absence of compromise and with reliable follow-up. This choice does not mean that risk is zero, but rather balances natural history against the risks of a procedure that may be followed by recurrence.

Longitudinal evidence requires critical interpretation. A prospective cohort of large chronic idiopathic effusions showed frequent reduction and regression in some patients; other observations document reaccumulation after drainage. These findings support a less invasive strategy in selected patients but do not come from a universal randomized comparison. They cannot be extrapolated to suspected infection, malignancy requiring characterization, major symptoms or rapid growth, where the balance is different.

The conservative plan should specify what is monitored, when the examination is repeated and how urgent assessment can be obtained. New pain, increasing dyspnea, presyncope, syncope or reduced urine output require attention. Difficulty accessing follow-up may change the decision, along with comorbidities and preferences. Observation is an active, documented strategy: it must be possible to abandon it promptly if findings emerge that make drainage useful or reopen the search for the cause.

Indications for drainage and procedural management

Clinical tamponade requires timely decompression, with priority determined by perfusion and the rate of deterioration. Persistent symptomatic collections or specific etiologic suspicions may also indicate drainage even without circulatory collapse. The decision should state whether the goal is therapeutic, diagnostic, or both. Large size alone does not make the benefit equivalent in every patient, whereas a relatively small collection may require intervention when it causes regional compression or accumulates rapidly.

Imaging-guided pericardiocentesis selects access according to location, distance and intervening structures, with sterile technique and monitoring. The route is not chosen automatically according to a traditional anatomic point. Coagulopathy, thrombocytopenia and antithrombotic drugs are assessed and corrected when possible without turning a relative contraindication into an absolute barrier in a life-saving emergency. Expertise and the ability to manage complications are part of choosing the care setting.

A pericardial catheter allows progressive evacuation and assessment of residual production, with duration adapted to cause and response. The diagnostic sample should be collected and sent according to arrangements with the laboratory and pathology service, especially when special analyses are needed. Amount and character of drainage are interpreted together with the clinical picture. Low output does not prove that the sac is empty if the catheter is obstructed, malpositioned or isolated from a loculation.

A surgical approach is indicated when percutaneous access is not feasible or sufficient, when clots or complex collections are present, in purulent infection, or when a lesion must be treated. A window may be chosen for selected recurrences and allows tissue sampling, but carries its own risks. In bleeding from cardiac rupture or aortic disease, the strategy must aim at repair, not simple evacuation. Uncoordinated drainage may alter the hemostatic tamponade of the lesion and requires urgent specialist assessment.

Controlled decompression and monitoring are particularly important in large or chronic collections. Pericardial decompression syndrome is a rare deterioration with ventricular dysfunction or pulmonary edema after evacuation, whose pathogenesis is not completely understood. No single rate or amount eliminates risk in every patient. The immediate objective is to resolve compromise, continuing management under surveillance and promptly reassessing unexpected deterioration.

Procedural complications include cardiac or vascular injury, arrhythmias, bleeding, pneumothorax and infection. After the procedure, circulatory status, cardiac function, residual fluid and the possibility of reaccumulation are monitored. If elevated jugular venous pressure or congestion persists with reduced fluid, effusive-constrictive physiology and other causes are investigated. Technical success does not end treatment: cytologic and microbiologic results, therapy of the cause and the surveillance plan must be integrated before the episode is considered resolved.

Prognosis, complications and long-term follow-up

Etiologic prognosis is often more informative than size. Stable idiopathic collections may have a favorable course, whereas infection, malignancy or hemorrhagic injury carries specific risks. Effusion may be a marker of severity of a systemic disease without being its main determinant. Therefore, mortality associated with the context should be distinguished from that directly attributable to compression or pericardial complications, avoiding excessive causal interpretations of observational studies.

Reaccumulation after drainage may result from still-active disease, lymphatic obstruction, persistent leakage or anatomic organization. Subsequent decisions require assessment of rate, symptoms and findings obtained, not merely noting that the fluid has returned. In some forms, repeating percutaneous access is appropriate; in others, a window or different etiologic treatment is preferable. Any post-procedural inflammation must also be distinguished from the original cause.

Constrictive progression depends mainly on etiology and organization of the process, not simply on the presence of a large collection. Specific infections, radiation injury and other conditions may increase risk. Persistent signs of congestion after fluid reduction require functional assessment. A thickened pericardium is not automatically equivalent to constriction, and normal thickness does not exclude it: diagnosis and treatment are based on physiology and reversibility.

Echocardiographic monitoring should use reproducible measurements and report clinically meaningful changes. In stable moderate or large idiopathic forms, follow-up at intervals of months may be appropriate, whereas growth or a recent diagnosis requires shorter intervals. Timing is individualized according to cause, symptoms and reliability of surveillance. A variation of a few millimeters between technically different studies should not automatically be called progression without considering imaging window, position and hemodynamic conditions.

Functional recovery depends on inflammatory activity and associated heart disease. Exercise restrictions prescribed in active pericarditis do not apply identically to every minimal incidental non-inflammatory effusion. After tamponade or procedures, return to activities requires stability and control of the cause. Trends in dyspnea and independence help measure benefit, while disappearance of fluid alone does not guarantee that all determinants of limitation have resolved.

Etiologic reassessment remains necessary when fever, weight loss, cytopenias, rapid growth or new organ signs appear. The initial label of idiopathic should not become a permanent constraint. Clear documentation of investigations already performed avoids unnecessary repetition and facilitates selection of subsequent tests. Effective follow-up links natural history, diagnostic results and shared decisions, maintaining attention to changes that can transform a stable finding into a condition requiring active treatment.

References
1. Schulz-Menger J et al. 2025 ESC Guidelines for the management of myocarditis and pericarditis. European Heart Journal. 2025;46(40):3952-4041.
2. Klein AL et al. Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging. JACC: Cardiovascular Imaging. 2024;17(8):937-988.
3. Adler Y et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2015;36(42):2921-2964.
4. Roberts WC. Pericardial heart disease: its morphologic features and its causes. Proceedings (Baylor University Medical Center). 2005;18(1):38-55.
5. Spodick DH. Acute cardiac tamponade. New England Journal of Medicine. 2003;349(7):684-690.
6. Mori S et al. Pericardial effusion in oncological patients: current knowledge and principles of management. Cardio-Oncology. 2024;10:8.
7. Rosen RJ, Valeri AM. Management of Patients with Kidney Failure and Pericarditis. Clinical Journal of the American Society of Nephrology. 2023;18(2):270-272.
8. Mayosi BM et al. Tuberculous pericarditis. Circulation. 2005;112(23):3608-3616.
9. Sagristà-Sauleda J et al. Purulent pericarditis: review of a 20-year experience in a general hospital. Journal of the American College of Cardiology. 1993;22(6):1661-1665.
10. Saab J et al. Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens. Cancer Cytopathology. 2017;125(2):128-137.
11. Ben-Horin S et al. The composition of normal pericardial fluid and its implications for diagnosing pericardial effusions. American Journal of Medicine. 2005;118(6):636-640.
12. Verma B et al. Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review. Heart. 2023;109(17):1281-1285.
13. Imazio M et al. Outcomes of idiopathic chronic large pericardial effusion. Heart. 2019;105(6):477-481.
14. Lazaros G et al. Long-Term Outcome of Pericardial Drainage in Cases of Chronic, Large, Hemodynamically Insignificant, C-Reactive Protein Negative, Idiopathic Pericardial Effusions. American Journal of Cardiology. 2020;126:89-93.
15. Sarode K et al. Pericardial Decompression Syndrome: A Comprehensive Review of a Controversial Entity. International Journal of Angiology. 2024;33(3):139-147.
16. Sagristà-Sauleda J et al. Effusive-constrictive pericarditis. New England Journal of Medicine. 2004;350(5):469-475.
17. Welch TD et al. Echocardiographic diagnosis of constrictive pericarditis: Mayo Clinic criteria. Circulation: Cardiovascular Imaging. 2014;7(3):526-534.